Newswise Curated News Channel: National Institute of Allergy and Infectious Diseases (NIAID)

In Memoriam: Diane Edmund Griffin, MD, PhD, 1940-2024

Johns Hopkins Bloomberg School of Public Health — Thu, 31 Oct 2024 15:45:07 EST

Diane Griffin, MD, PhD, a pioneering infectious-disease virologist, scientific leader, and Johns Hopkins professor, died Monday. She was 84.

Study: AI Could Transform How Hospitals Produce Quality Reports

UC San Diego Health — Mon, 21 Oct 2024 11:35:46 EST

University of California San Diego School of Medicine researchers find advanced AI could lead to easier, faster and more efficient hospital quality reporting.

Houston Methodist Prepares for Next Pandemic as Part of National NIH-Funded Consortium

Houston Methodist — Thu, 03 Oct 2024 19:05:13 EST

The question isn't if, but when, the next pandemic will hit. Research and observation have identified strong potential for the next pandemic-causing virus to come from one or more of five different virus families.

Triple Antibody Therapy Shows Promise for Long-Lasting HIV Control

Beth Israel Lahey Health — Thu, 12 Sep 2024 09:05:26 EST

In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.

T helper cells may be the key to improving annual influenza vaccines

St. Jude Children's Research Hospital — Tue, 20 Aug 2024 10:05:28 EST

The annual influenza vaccination provides updated protection against the virus but could be improved as there is large variability in its efficacy.

Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients

Johns Hopkins Medicine — Fri, 18 Aug 2023 12:05:42 EST

A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus' omicron subvariant.

Immune cells present long before infection predict flu symptoms

St. Jude Children's Research Hospital — Thu, 17 Aug 2023 12:35:01 EST

St. Jude Children's Research Hospital scientists found that immune cells present in individuals long before influenza infection predict whether the illness is symptomatic.

UTSW finds potential key to predict immunotherapy toxicity

UT Southwestern Medical Center — Mon, 14 Aug 2023 11:50:25 EST

Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity. The findings, published in the Journal for ImmunoTherapy of Cancer, could lead to improved treatments for a variety of cancers.

Academic-private partnership aims to reduce toxic effects of deadly digestive bacteria

Virginia Tech — Wed, 09 Aug 2023 10:20:28 EST

The bacterium commonly referred to as C. diff is sometimes called "C-difficult" because it is so hard to treat, said Mohamed Seleem, director of the Center for One Health Research. Seleem and Nectagen Inc. have received a nearly $275,000 grant from the National Institute of Allergy and Infectious Diseases to study whether synthetic proteins developed by Nectagen can reduce the toxicity of the digestive bacteria.

Alternative cellular 'fuels' boost immunity

Van Andel Institute — Fri, 28 Jul 2023 11:05:11 EST

A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by Van Andel Institute scientists and collaborators.

Study explores how often children diagnosed with flu experience serious neuropsychiatric side effects

Vanderbilt University Medical Center — Mon, 24 Jul 2023 11:40:35 EST

While the incidence of influenza-associated neuropsychiatric events in children in the United States is unknown, the controversy over the use of a common antiviral medication typically administered to treat flu in children has sparked concern among parents and medical professionals alike. The dilemma about whether the treatment causes neuropsychiatric events or if the infection itself is the culprit, led a group of pediatric researchers at Monroe Carell Jr.

ASBMB expresses concerns on proposed NIH budget cuts

American Society for Biochemistry and Molecular Biology (ASBMB) — Fri, 21 Jul 2023 10:00:10 EST

ASBMB publishes a statement expressing concerns for NIH budget cuts outlined by a House Labor HHS funding bill that could lead to lost jobs and halted research progress

New Community Partnership Model Boosts Inclusion of Participants into HIV Cure-Directed Research

Wistar Institute — Wed, 19 Jul 2023 12:05:09 EST

Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, Wistar Institute researchers are sharing how a more inclusive model for community engagement can lead to deeper insights and greater community participation in HIV research.

Virginia Tech awarded grant to study lingering Lyme disease symptoms

Virginia Tech — Fri, 14 Jul 2023 16:05:18 EST

An estimated 1,200 Americans, on average, are diagnosed with Lyme disease each day. Some of those patients continue to experience negative effects, even after treatment. Lyme disease researcher Brandon Jutras, associate professor in the College of Agriculture and Life Sciences and affiliated faculty of the Fralin Life Sciences Institute, recently received a $2.

Proteins Predict Significant Step Toward Development of Diabetes

Pacific Northwest National Laboratory — Thu, 29 Jun 2023 11:00:00 EST

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Icahn School of Medicine at Mount Sinai Researchers Awarded $15.1 Million Grant to Explore Immune Rejection of Transplanted Organs

Mount Sinai Health System — Wed, 28 Jun 2023 15:05:19 EST

Striving to improve organ transplant survival rates, internationally renowned researchers in immunology and bioengineering at the Icahn School of Medicine at Mount Sinai have received $15.1 million from the National Institute of Allergy and Infectious Diseases (NIAID) to lead a novel, five-year multi-center research program that will explore trained immunity--the innate immune system's ability to remember infections and other insults--as a target for preventing organ transplant rejection.

CDI Lab Earns Grant to Re-engineer Drugs to Combat Emerging Infections

Hackensack Meridian Health — Thu, 22 Jun 2023 12:05:10 EST

A laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) has been issued a major grant to repurpose drugs to combat non-tuberculous mycobacteria (NTM), an emerging family of germs naturally found in soil and water and which can be deadly to those with compromised immune systems and pre-existing lung diseases.

People who preserve 'immune resilience' live longer, resist infections

University of Texas Health Science Center at San Antonio — Tue, 13 Jun 2023 19:50:46 EST

Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress -- called "immune resilience" -- differs widely among individuals.

CHOP Researchers Develop Universal MHC Molecules that Can be Produced Rapidly at Scale

Children's Hospital of Philadelphia — Tue, 13 Jun 2023 14:55:41 EST

Researchers from Children's Hospital of Philadelphia (CHOP) have engineered stable, universal MHC-I molecules that can be produced rapidly at scale, allowing researchers not only to develop vaccines and immunotherapies more quickly but also to identify molecules that can work broadly across the population. The findings were published today in the Proceedings of the National Academy of Sciences.

Family resemblance: How T cells could fight many coronaviruses at once

La Jolla Institute for Immunology — Thu, 01 Jun 2023 15:00:55 EST

Scientists at La Jolla Institute for Immunology show that T cells can recognize several different viral targets, called "antigens," shared between most coronaviruses, including common cold coronaviruses and SARS-CoV-2. They also looked more in-depth at what fragments of these antigens, called "epitopes," are recognized and how conserved they are across different coronaviruses.